SMYD3 induces transcriptional activation of AR (Vieira et al., 2015) and as a consequence, PCa tissues displayed higher SMYD3 levels compared to normal prostate in advanced stages of disease (Vieira et al., 2014). Here, SMYD3 is linked to posterior cortical atrophy.